ArticleScientific reports2025
Development and validation of a machine learning-based model to predict the risk of hospitalization death in hospitalized patients with AECOPD.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Development and multicenter validation of machine learning models for 28-day mortality in critically ill patients with acute exacerbation of chronic obstructive pulmonary disease.BMC pulmonary medicine · 2026Article
- Artificial Intelligence for Early Detection and Prediction of Chronic Obstructive Pulmonary Disease Exacerbations.Healthcare (Basel, Switzerland) · 2026Review
- Development and External Validation of a Machine Learning Model for 90-Day Readmission in Hospitalized Older Patients with AECOPD: A Two-Center Study.International journal of chronic obstructive pulmonary disease · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is a leading cause of hospitalization and death in COPD patients. Machine learning (ML) approach is powerful but has a "black box" issue with an undirect interpretation of the ML technique. Herein, we conducted a multicentre, retrospective cohort study in two tertiary hospitals across China, primarily utilizing echocardiographic variables to build and validate an explainable prediction model based on a ML approach to predict the hospitalization death of AECOPD. For model explainability, we utilized a model-agnostic SHapley Additive exPlanations explainer to interpret the output of our final model. Our results showed that the light gradient boosting machine (LightGBM) model achieved the best performance among the 11 ML models. After reducing features according to the feature importance rank, an explainable final LightGBM model was established with 9 features (AUC = 0.956, accuracy = 92.1%, sensitivity = 0.891, specificity = 0.933, PPV = 0.852, NPV = 0.952, F1 score = 0.871). To facilitate its utility for clinicians, this final explainable model had been translated into a convenient application. In addition, the LightGBM model mitigated the concern of the "black-box" via a global and a local explanation of the SHAP method. A publicly accessible web tool was generated for the model. These findings further hold promise for guiding clinical management and improving patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.